Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
HIV Dementia
Interventions
DRUG

Ferumoxytol

A dose of 4 mg/kg of ferumoxytol up to a maximum of 510 mg of elemental iron will be administered.

Trial Locations (1)

96816

Hawaii Center for AIDS, Honolulu

All Listed Sponsors
collaborator

Oregon Health and Science University

OTHER

lead

University of Hawaii

OTHER

NCT01665846 - Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders | Biotech Hunter | Biotech Hunter